Overall Fundamental outlook

*SUVENPHAR makes the list of companies with the worst fundamentals at present.

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Suven Pharmaceuticals Limited operates as a bio-pharmaceutical company in India, the United States, Europe, and internationally. It develops, manufactures, and sells new chemical entity-based intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs under contract research and manufacturing services for pharmaceutical, biotechnology, and chemical companies. The company was founded in 1989 and is based in Hyderabad, India. Suven Pharmaceuticals Limited is a subsidiary of Berhyanda Limited.

Revenue projections:

Revenue projections for SUVENPHAR
Revenue projections for SUVENPHAR

With Suven Pharmaceuticals Limited's revenue forecasted to drop below last year's level, investors are expected to take a cautious stance. Such declines typically affect a company's bottom line, reducing profitability and making investors hesitant to invest heavily in the company until financial performance improves.

Financial Ratios:

currentRatio 0.0
forwardPE 0.0
debtToEquity 0.0
earningsGrowth 0.0
revenueGrowth 0.0
grossMargins 0.0
operatingMargins 0.0
trailingEps 0.0
forwardEps 0.0


Price projections:

Price projections for SUVENPHAR
Price projections for SUVENPHAR

The current price of SUVENPHAR, relative to its projections, shows no clear risks or opportunities. This neutral assessment may encourage investors to take a cautious approach, awaiting further developments before making substantial changes.

Recommendation changes over time:

Recommendations trend for SUVENPHAR
Recommendations trend for SUVENPHAR


A recent buy bias from analysts toward SUVENPHAR may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that SUVENPHAR might be an appealing option for those looking to grow their wealth through stock market investments.